Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Iberdomide Promising for Cutaneous Lupus in Phase 2 Study
TOPLINE: Patients with cutaneous lupus erythematosus (CLE) experienced improved symptoms with iberdomide, a cereblon modulator, added to standard lupus medications, particularly in subacute and chronic cases. METHODOLOGY: Researchers conducted a randomized phase 2 trial to evaluate the efficacy and safety…
English